Unsolicited applications

Momentum Biotechnologies EU (former OmicScouts) at a glance We are looking for a bioinformatics scientist to join our interdisciplinary team. You will become an important part of the team working cross-functionally with other groups in the company and supporting the development and analysis of proteomics data analysis for challenging and exciting customer and R&D projects. You'll drive the development of our data products and bridge science and business development department. Collaborate effectively in an multifaceted environment, and actively foster transparent, solution-oriented dialogue within the team. Our offer: You are part of an experienced, highly motivated and diverse team You receive individually tailored training, gain experience and assume increasing responsibility for your area of expertise You work in a company with flat hierarchies, short decision-making processes and an active culture of discussion You have the option to work in a hybrid environment (depending on the specific job). You receive an attractive remuneration package, the offer of a company pension scheme and flexible working hours You have 30 days vacation You can strengthen yourself with our fabulous espresso, fresh fruit and free lunch catering on our "DeliciOS-Wednesday" You can look forward to our bi-yearly company celebrations that always include a team event such as climbing, rafting or star gazing and are invited to participate in other team activities such as relay marathon runs or city cycling challenges You have the opportunity to become a member of our company fitness provider EGYM Wellpass About us Momentum Biotechnologies EU (former OmicScouts GmbH) founded in 2014, is a proteomics company focused on supporting drug and biomarker discovery through unique expertise and innovative technologies. By providing and developing system-wide assays to monitor protein activity and function in a physiological context, OmicScouts enables the identification of small molecule drug targets, target engagement markers, molecular mechanisms of action, and drug response biomarkers. OmicScouts supports a wide variety of drug and biomarker discovery projects with end-to-end solutions tailored to project-specific needs, and the team has a strong track record of successful collaborations with top pharmaceutical and biotechnology companies. In 2025, OmicScouts was acquired by Momentum, a Biotechnology company based close to Boston, Massachusetts. expanding to the US market. It now operates as OmicScouts, a Momentum Biotechnologies Company. For more information, please visit www.omicscouts.com and www.momentum.bio .